WHAT: Widely used medication not effective for most patients with chronic obstructive pulmonary disease (COPD)
A recent study, conducted at Mayo Clinic and published in the December 28th edition of the New England Journal of Medicine, has found that patients who suffer from chronic obstructive pulmonary disease (COPD) receive very little long-term benefit from the use of inhaled corticosteroids.
These widely prescribed medications do not inhibit the decline in lung function caused by the disease and offer only a slight reduction in specific flare-ups of the disease. Negative side effects from the medications also were observed.
WHEN: Wednesday, December 27, 2000
Eastern
Test 14:00-14:05 (EST)
Program 14:05-14:30
Central
Test 13:00-13:05 (CST)
Program 13:05-13:30
Satellite Coordinates
Ku-Band
Satellite: Galaxy 11
Transponder: 13 (H)
Channel: 13
Downlink Frequency: 11960 MHz
Audio: 6.2 or 6.8 MHz
Longitude: 91° W
C-Band
Satellite: Galaxy 4
Transponder: 12 (V)
Channel: 12
Downlink Frequency: 3940 MHz
Audio: 6.2 or 6.8 MHz
Longitude: 99° W
Technical Questions Prior to Broadcast ONLY:
Mayo Clinic Video Communications;
507-284-5964.
Satellite Technical Difficulties: Strategic Television; 800-608-3663.
Video Feed: A video feed, including sound bites from the study's principal investigator and b-roll will be fed via satellite at 2 p.m. CST on Wed., Dec. 27.
Lee Aase
507-266-2442 (days)
507-284-2511 (evenings)
newsbureau@mayo.edu
Chris Gade
507-284-2430 (days)
507-284-2511 (evenings)
newsbureau@mayo.edu
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.